Effect of raloxifene (a Selective Estrogen Receptor Modulator (SERM)) as coadjuvant to antidepressant treatment: A case report

Actas Espanolas de Psiquiatria

Volumn 39, Issue 5, 2011, Pages 334-335

  Usall, Judith ^a,b   Coromina, Marta ^a,c   Araya, Susana ^a   Ochoa, Susana ^a,b,c  

^a PARC SANITARI SANT JOAN DE DÉU   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c Grup de Treball I Reeerca en Dona i Salut Mental ^*  (Spain)

Author keywords

Depressive disorder; Estrogens; Raloxifene; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ARTICLE; CASE REPORT; DEPRESSION; DRUG COMBINATION; FEMALE; HUMAN; MIDDLE AGED;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 82455209505     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Rasgon NL, Altshuler LL, Fairbanks LA, Dunkin JJ, Davtyan C, Elman S, et al. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry 2002;63(suppl 7):45-8.
2. Zanardi R, Rossini L, Magri A, Malaguti A, Colombo C, Smeraldi E. Response to SSRIs and role of the hormonal therapy in postmenopausal depression.Eur Neuropsychopharmacol 2007;17:400-5.
3. Usall J. Use of estrogens in the treatment of mental disorders. Adas EspPsiquiatr 2003;31(4):199-204.
4. Cyr M, Calon F, Morissette M, Grandbois M, Di Paolo T, Callier S. Drugswith estrogen-like and brain activity: potential therapeutic application for the CNS. Curr Pharm Des 2000;6(12):1287-312.
5. Landry M, Lévesque D, Di Paolo T. Estrogenic properties of raloxifene, but not tamoxifene, on D2 and D3 dopamine receptors in the rat forebrain. Neuroendocrinology 2002;76:214-22.
6. Freeman EW, Sammel MD, Liu L Hormones and menopausal status as predictor of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62-70.
7. Pinto-Meza A, Usall J, Serrano-Bianco A, Graaf RD, Demyttenaere K, Alonso J, et al. Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference? J Affect Disord 2006;93:53-60.
8. Jarkova NB, Martenyi F, Masanauskaite D, Walls EL, Smetnik VP, Pavo I. Mood effect of raloxifene in postmenopausal women. Maturitas2002;42(1):71-5.
9. Karageyim Karsidag AY, Karsidag C, Buyukbayrak EE, Kars B, Pirimoglu M,Unal 0, Turan MC. Raloxifene: is it really effective on mood changes in postmenopausal osteopenic women? J Psychosom Obstet Gynaecol 2010;31(4):273-8.
10. Grigoriadis S, Kennedy SH, Srinivisan J, Mclntyre RS, Fulton K. Antidepressant Augmentation with raloxifene. J Clin Psychopharmacol 2005;25:96-8.
11. Sugiyama N, Sasayama D, Amano N. Remarkable Antidepressant Augmentation Effect of raloxifene, a Selective estrogen Receptor Modulator, in a Partial Responder to Fluvoxamine: A case report.J Clin Psychiatry 2007;68:636-7.